Donna Mildvan

13.7k total citations · 3 hit papers
130 papers, 9.6k citations indexed

About

Donna Mildvan is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Donna Mildvan has authored 130 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Infectious Diseases, 58 papers in Epidemiology and 55 papers in Virology. Recurrent topics in Donna Mildvan's work include HIV Research and Treatment (54 papers), HIV/AIDS Research and Interventions (50 papers) and HIV/AIDS drug development and treatment (29 papers). Donna Mildvan is often cited by papers focused on HIV Research and Treatment (54 papers), HIV/AIDS Research and Interventions (50 papers) and HIV/AIDS drug development and treatment (29 papers). Donna Mildvan collaborates with scholars based in United States, Israel and United Kingdom. Donna Mildvan's co-authors include Paul A. Volberding, Oscar L. Laskin, Michael H. Grieco, Margaret A. Fischl, Douglas D. Richman, Michael S. Gottlieb, Jerome E. Groopman, George Gee Jackson, John M. Leedom and David T. Durack and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Donna Mildvan

130 papers receiving 8.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex

1987 2.3k citations Margaret A. Fischl, Paul A. Volberding et al. profile →
The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex

1987 975 citations Margaret A. Fischl, Paul A. Volberding et al. profile →
Acquired Immunodeficiency Syndrome (AIDS) Associated with Transfusions

1984 411 citations Donna Mildvan et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Donna Mildvan	5.3k	3.9k	3.7k	1.5k	1000	130	9.6k
James M. Oleske	5.5k 1.0×	3.3k 0.8×	4.9k 1.3×	2.5k 1.7×	1.9k 1.9×	205	11.2k
Michael S. Gottlieb	4.1k 0.8×	3.4k 0.9×	3.3k 0.9×	1.6k 1.1×	523 0.5×	41	8.3k
Robert T. Schooley	8.2k 1.5×	3.6k 0.9×	6.5k 1.7×	962 0.7×	1.5k 1.5×	67	11.9k
D. William Cameron	4.1k 0.8×	2.9k 0.8×	2.1k 0.6×	1.5k 1.0×	660 0.7×	294	9.7k
Philippe Van de Perre	7.3k 1.4×	5.7k 1.5×	3.2k 0.9×	926 0.6×	1.1k 1.1×	402	12.2k
Craig W. Hendrix	5.7k 1.1×	3.6k 0.9×	3.4k 0.9×	1.8k 1.2×	458 0.5×	259	9.8k
Michael A. Polis	3.5k 0.7×	2.9k 0.7×	4.3k 1.2×	2.8k 1.9×	832 0.8×	143	8.6k
Charles Flexner	5.7k 1.1×	2.4k 0.6×	5.3k 1.4×	1.9k 1.3×	921 0.9×	181	10.8k
Richard B. Pollard	3.7k 0.7×	3.8k 1.0×	3.7k 1.0×	2.9k 2.0×	1.1k 1.1×	268	10.4k
Shinichi Oka	4.3k 0.8×	2.8k 0.7×	3.2k 0.9×	1.4k 1.0×	879 0.9×	475	8.1k

Countries citing papers authored by Donna Mildvan

Since Specialization

Citations

This map shows the geographic impact of Donna Mildvan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Mildvan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Mildvan more than expected).

Fields of papers citing papers by Donna Mildvan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Mildvan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Mildvan. The network helps show where Donna Mildvan may publish in the future.

Co-authorship network of co-authors of Donna Mildvan

This figure shows the co-authorship network connecting the top 25 collaborators of Donna Mildvan. A scholar is included among the top collaborators of Donna Mildvan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna Mildvan. Donna Mildvan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tillotson, Glenn, Thomas P. Lodise, Peter Classi, Donna Mildvan, & James A. McKinnell. (2020). Antibiotic Treatment Failure and Associated Outcomes Among Adult Patients With Community-Acquired Pneumonia in the Outpatient Setting: A Real-world US Insurance Claims Database Study. Open Forum Infectious Diseases. 7(3). ofaa065–ofaa065. 14 indexed citations

Gwadz, Marya, Charles M. Cleland, Elizabeth Applegate, et al.. (2015). Behavioral Intervention Improves Treatment Outcomes Among HIV-Infected Individuals Who Have Delayed, Declined, or Discontinued Antiretroviral Therapy: A Randomized Controlled Trial of a Novel Intervention. AIDS and Behavior. 19(10). 1801–1817. 31 indexed citations

Gwadz, Marya, Elizabeth Applegate, Charles M. Cleland, et al.. (2014). HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited Cohorts. Frontiers in Public Health. 2. 81–81. 26 indexed citations

Gwadz, Marya, Charles M. Cleland, Noelle R. Leonard, et al.. (2012). Predictors of Screening for AIDS Clinical Trials Among African-Americans and Latino/Hispanics Enrolled in an Efficacious Peer-Driven Intervention: Uncovering Socio-Demographic, Health, and Substance Use-Related Factors That Promote or Impede Screening. AIDS and Behavior. 17(2). 801–812. 9 indexed citations

Ruhe, Jörg & Donna Mildvan. (2012). Does Empirical Therapy with a Fluoroquinolone or the Combination of a β-Lactam Plus a Macrolide Result in Better Outcomes for Patients Admitted to the General Ward?. Infectious Disease Clinics of North America. 27(1). 115–132. 13 indexed citations

Gwadz, Marya, Amanda S. Ritchie, Noelle R. Leonard, et al.. (2010). Increasing and Supporting the Participation of Persons of Color Living with HIV/AIDS in AIDS Clinical Trials. Current HIV/AIDS Reports. 7(4). 194–200. 26 indexed citations

King, William D., Kimberly Y. Smith, Janet Andersen, et al.. (2007). Attitudes and Perceptions of AIDS Clinical Trials Group Site Coordinators on HIV Clinical Trial Recruitment and Retention: A Descriptive Study. AIDS Patient Care and STDs. 21(8). 551–563. 24 indexed citations

Vogler, Mary, Hedy Teppler, Rebecca Gelman, et al.. (2004). Daily Low-Dose Subcutaneous Interleukin-2 Added To Single- or Dual-Nucleoside Therapy in HIV Infection Does Not Protect Against CD4+ T-Cell Decline or Improve Other Indices of Immune Function: Results of a Randomized Controlled Clinical Trial (ACTG 248). JAIDS Journal of Acquired Immune Deficiency Syndromes. 36(1). 576–587. 15 indexed citations

Volberding, Paul A., A Levine, Douglas T. Dieterich, et al.. (2004). Anemia in HIV Infection: Clinical Impact and Evidence-Based Management Strategies. Clinical Infectious Diseases. 38(10). 1454–1463. 192 indexed citations

10.

Mildvan, Donna. (2003). Implications of Anemia in Human Immunodeficiency Virus, Cancer, and Hepatitis C Virus. Clinical Infectious Diseases. 37(s4). S293–S296. 9 indexed citations

11.

Spritzler, John, Donna Mildvan, Daniella Livnat, et al.. (2003). Can Immune Markers Predict Subsequent Discordance between Immunologic and Virologic Responses to Antiretroviral Therapy? Adult AIDS Clinical Trials Group. Clinical Infectious Diseases. 37(4). 551–558. 17 indexed citations

12.

Sha, Beverly E., Hernán Valdez, Rebecca Gelman, et al.. (2002). Short Communication : Effect of Etanercept (Enbrel) on Interleukin 6, Tumor Necrosis Factor α , and Markers of Immune Activation in HIV-Infected Subjects Receiving Interleukin 2. AIDS Research and Human Retroviruses. 18(9). 661–665. 39 indexed citations

13.

Mildvan, Donna, et al.. (2002). Pharmacokinetic Interaction Between Nevirapine and Ethinyl Estradiol/Norethindrone When Administered Concurrently to HIV-Infected Women. JAIDS Journal of Acquired Immune Deficiency Syndromes. 29(5). 471–477. 64 indexed citations

14.

Mildvan, Donna. (2000). Surrogate Markers: The AIDS Clinical Trials. Archives of Neurology. 57(8). 1233–1233. 1 indexed citations

15.

Zackin, Robert, Rebecca A. Clark, Judith S. Currier, & Donna Mildvan. (1999). Predictive Markers of HIV-Related Weight Loss and Determination of Differences Between Populations With Weight Loss Stratified by Opportunistic Processes. JAIDS Journal of Acquired Immune Deficiency Syndromes. 22(2). 189–189. 7 indexed citations

16.

Mildvan, Donna, Jonathan Kagan, Scott L. Zeger, et al.. (1998). Abstracts of the NIH‐FDA Conference “Biomarkers and Surrogate Endpoints: Advancing Clinical Research and Applications”. Disease Markers. 14(4). 187–334. 10 indexed citations

17.

Croxson, T S, Usha Mathur‐Wagh, S Handwerger, et al.. (1990). Prognostic Significance of Quantitative Levels of HIV p24 Binding Capacity in HIV Infection. AIDS Research and Human Retroviruses. 6(4). 455–463. 11 indexed citations

18.

Orron, Dan E., et al.. (1989). Primary cerebral lymphoma in acquired immunodeficiency syndrome (AIDS)—CT manifestations. Computerized Medical Imaging and Graphics. 13(2). 207–214. 4 indexed citations

19.

Talavera, Wilfredo & Donna Mildvan. (1986). Pulmonary infections in the acquired immunodeficiency syndrome.. PubMed. 1(3). 202–11. 9 indexed citations

20.

Mildvan, Donna, et al.. (1977). The spectrum and causes of liver diseases in narcotic addicts.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 67(4). 314–8. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact